Bentham Science Logo

Current Cancer Drug Targets

Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Open Access Articles

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer

, 2019; 19(1): 74 - 80

Peng Liu, Hailin Tang, Jiali Wu, Xingsheng Qiu, Yanan Kong, Lijuan Zhang, Xinhua Xie* and Xiangsheng Xiao*















Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy

, 2013; 13(7): 724 - 734

Gudmundur V. Helgason, Arunima Mukhopadhyay, Maria Karvela, Paolo Salomoni, Bruno Calabretta and Tessa L. Holyoake








miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents

, 2013; 13(5): 519 - 541

Biyun Qian, Subhasree A. Nag, Yuliang Su, Sukesh Voruganti, Jiang-Jiang Qin, Ruiwen Zhang and William C. S. Cho




VEGF in Tumor Progression and Targeted Therapy

, 2013; 13(4): 423 - 443

Vladimir P. Chekhonin, Sergey A. Shein, Anna A. Korchagina and Olga I. Gurina




Nanomedicines as Cancer Therapeutics: Current Status

, 2013; 13(4): 362 - 378

Sohail Akhter, Iqbal Ahmad, Mohammad Zaki Ahmad, Farshad Ramazani, Anjali Singh, Ziyaur Rahman, Farhan Jalees Ahmad, Gert Storm and Robbert J. Kok





Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma

, 2013; 13(3): 300 - 312

Jordi Muntane, Angel J. De la Rosa, Fernando Docobo, Rocio Garcia-Carbonero and Francisco J. Padillo











Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma

, 2012; 12(7): 838 - 846

P. Tagliaferri, M. Rossi, M. T. Di Martino, N. Amodio, E. Leone, A. Gulla, A. Neri and P. Tassone




MicroRNAs in the Pathobiology of Multiple Myeloma

, 2012; 12(7): 823 - 837

Marta Lionetti, Luca Agnelli, Luigia Lombardi, Pierfrancesco Tassone and Antonino Neri





Molecular Targets for the Treatment of Multiple Myeloma

, 2012; 12(7): 757 - 767

Marco Rossi, Maria Teresa Di Martino, Eugenio Morelli, Marzia Leotta, Antonietta Rizzo, Anna Grimaldi, Gabriella Misso, Pierfrancesco Tassone and Michele Caraglia





High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer

, 2012; 12(6): 693 - 702

C. D'Alterio, L. Portella, A. Ottaiano, M. Rizzo, G. Carteni, S. Pignata, G. Facchini, S. Perdona, G. Di Lorenzo, R. Autorino, R. Franco, A. La Mura, O. Nappi, G. Castello and S. Scala




Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells

, 2012; 12(5): 531 - 542

R. Lappano, C. Rosano, M. F. Santolla, M. Pupo, E. M. De Francesco, P. De Marco, M. Ponassi, A. Spallarossa, A. Ranise and M. Maggiolini





An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

, 2012; 12(4): 439 - 452

Nicola Tinari, Michele De Tursi, Antonino Grassadonia, Marinella Zilli, Liborio Stuppia, Stefano Iacobelli and Clara Natoli






Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier

, 2012; 12(3): 186 - 196

M. Caraglia, G. De Rosa, G. Salzano, D. Santini, M. Lamberti, P. Sperlongano, A. Lombardi, A. Abbruzzese and R. Addeo








Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

, 2010; 10(2): 155 - 167

A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer










Related Journals

Related eBooks

eBooks Catalog